Strategic Use of Advanced Technologies and Multiple Host Species to Rapidly Generate Cost-Effective Antibody Candidates

Back to Webinars

Featured Speakers: Iwona Budnicki, Ph.D., Manager, Cellular Immunology, Genovac | Donovan McGinley-Colman, Senior Scientist, Genovac | Danielle Borys, Senior Product Applications Scientist, Bruker Cellular Analysis

What's Inside

In this Webinar we discuss:

Enhanced Antibody Discovery with Multiple Host Species: Learn how leveraging diverse immune repertoires across multiple species improves success rates against difficult targets like RAGE.

AI-Powered Humanization & Lead Optimization: Discover how in silico humanization and machine learning accelerate lead identification and developability, reducing downstream engineering efforts.

Cutting-Edge Technologies for Faster Antibody Development: Explore how Genovac integrates the Beacon® optofluidic system, wild-type host systems, and advanced discovery platforms to streamline and accelerate antibody discovery and characterization.

Watch the Webinar

Back to the Top